Latest Sunitinib Stories
A British oncologist says he is dismayed that kidney cancer patients may be denied four new treatments due to cost. Dr.
EntreMed, a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, has met the primary endpoint for the efficacy portion of the open label Phase I/II study of MKC-1 in combination with pemetrexed in non-small cell lung cancer patients.
Infinity Pharmaceuticals, a cancer drug discovery and development company, has initiated a Phase III registration trial of IPI-504, its lead inhibitor of heat shock protein 90, in patients with refractory gastrointestinal stromal tumors.
ZymoGenetics, a developer of novel protein therapeutics, has announced positive interim results from a Phase II clinical trial evaluating interleukin 21 in combination with Nexavar tablets in patients with metastatic renal cell cancer.
CAMBRIDGE, Mass., Oct. 22 /PRNewswire/ -- Millennium: The Takeda Oncology Company today announced new data from early non-clinical studies of Millennium/Takeda-discovered pipeline molecules highlighting novel therapeutic pathways in oncology.
ZymoGenetics, Inc. (NASDAQ: ZGEN) presented interim results today from a Phase 2 clinical trial evaluating Interleukin 21 (IL-21) in combination with Nexavar(R) (sorafenib) tablets in patients with metastatic renal cell cancer.
WALTHAM, Mass., Oct.
Pfizer Inc today provided the latest update to its development pipeline, showing significant progress in achieving the company's growth, productivity and performance goals. The pipeline now includes 114 programs, from Phase 1 through Registration.
GRANDMOTHER Dorothy Isgrove, who was diagnosed with bowel cancer six years ago, has spoken of her daily battle to keep up her spirits and deal with her illness.
- A person or thing gazed at with wonder or curiosity, especially of a scornful kind.